Kidney Stone Breaker
Stone breaker contains 100% pure chancapiedra and is also known as kidneystone crushing. Chancapiedra (Phyllanthusniruri) is a native Amazonian plant. The entire plant can be used as medicine. Chancapiedra has a long history as a traditional remedy for many conditions. However, it is best known for its ability dissolve gallstones and gallstones.
Scientific evidence supports some of the traditional uses for chancapiedra. It is believed that chancapiedra can be beneficial to liver and kidney health as well as treatment and prevention of kidney stone formations. Experimental studies indicate that Phyllanthus niruri could interfere with key steps in the formation and maintenance of calculi. These include crystal aggregation, internalization by tubular cells, crystal structure, and composition. These properties could prove beneficial in the prevention or lithiasis. They might also inhibit calculus growth, keep the crystals from dispersing in the urine and facilitate their elimination. Although studies of Phyllanthus are few, evidence is available that it has positive effects. These include interfering with urinary crystallization promoters like calcium and facilitating the removal of fragments after lithotripsy. It is worth noting that although Phyllanthus niruri does interfere with some steps in stone formation, there are limited clinical studies that can prove this. Phyllanthus niruri was found to relax tubes that transport urine from kidneys to bladder. This may be beneficial because it can help eliminate substances that could cause kidney stones [13]. Nephrology Division at the Universidade Federal de Sao Paulo (Brazil) conducted a study to evaluate the effects of P. niruri on 24 h urinary biochemical parameters. This was done in order to determine its in vivo impact in patients with calcium stone formation (CSF). There were 69 CSF-related patients who received either P.niruri, or placebo over three months.
The baseline and end of the study were used to determine blood calcium, uric acids, citrates, magnesium, oxalate and sodium. One subset of patients was analysed for metabolic abnormalities. We found that P. niruri caused a significant decrease in urinary calcium levels in hypercalciuric patients. Based on analysis of hypercalciuria patients, the data suggests that P. Niruri intake decreases urinary calcium.
